tible 
loan with the same JV for EUR 1.0 million. Besides these transactions, IBA wrote off the 
11.4% (USD 2 million, EUR 1.8 million) stake in 
HIL Applied Medical Ltd, an Israelian developer 
of laser-based proton therapy systems. And IBA 
invested a further EUR 1.6 million in Invest BW, a regional venture capital partner that is 
providing financing and support to entrepreneurs 
in Walloon Brabant (cf. paragraph 5.5). The participations in affiliated companies (EUR 
129.4 million), contain among others the 
participation in the affilated company IBA 
Russia.